Tag: Optimi Health - Page 4 - Psychedelic Alpha

Read more about the article Optimi Health Dealer’s License Granted by Health Canada

Optimi Health Dealer’s License Granted by Health Canada

Post published:February 7, 2022
Post category:Press Release

Read more about the article Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent

Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent

Post published:January 18, 2022
Post category:Press Release

Read more about the article Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department

Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department

Post published:December 21, 2021
Post category:Press Release

Read more about the article Optimi Health Joins First Psychedelic Exchange Traded Fund

Optimi Health Joins First Psychedelic Exchange Traded Fund

Post published:July 14, 2021
Post category:Press Release

Read more about the article Optimi Health Completes Pre-Clinical Trial Application Meeting

Optimi Health Completes Pre-Clinical Trial Application Meeting

Post published:June 15, 2021
Post category:Press Release

Read more about the article Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol

Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol

Post published:May 4, 2021
Post category:Press Release

Read more about the article Optimi Health Large Scale Multi-Purpose Mushroom Facility Advances Towards Completion and Licensing

Optimi Health Large Scale Multi-Purpose Mushroom Facility Advances Towards Completion and Licensing

Post published:March 23, 2021
Post category:Press Release

Read more about the article Optimi Health Receives Health Canada NPN Product Licenses in Preparation for Q2 Sales Launch

Optimi Health Receives Health Canada NPN Product Licenses in Preparation for Q2 Sales Launch

Post published:March 16, 2021
Post category:Press Release

Read more about the article Optimi Health Accelerates Psilocybin Clinical Trial Program with IMPACT

Optimi Health Accelerates Psilocybin Clinical Trial Program with IMPACT

Post published:March 9, 2021
Post category:Press Release

Read more about the article OPTIMI HEALTH and NUMINUS WELLNESS to Conduct Psychedelic Lab Research and Development

OPTIMI HEALTH and NUMINUS WELLNESS to Conduct Psychedelic Lab Research and Development

Post published:March 2, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.